Man Group PLC Denali Therapeutics Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Man Group PLC holds 30,427 shares of DNLI stock, worth $709,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,427

Previous 37,545 18.96%

Holding current value

$709,253

Previous $871,000 1.72%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.96 - $31.05 $149,193 - $221,013	-7,118 Reduced 18.96%	30,427 $886,000
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $561,673 - $871,794	37,545 New	37,545 $871,000
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $1.68 Million - $2.46 Million	-81,604 Reduced 16.15%	423,610 $8.74 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $11.8 Million - $16.7 Million	505,214 New	505,214 $14.9 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $2.85 Million - $3.68 Million	108,508 Added 315.24%	142,929 $3.97 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $893,913 - $1.33 Million	34,421 New	34,421 $1.06 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $264,894 - $427,448	-5,464 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $2.67 Million - $4.16 Million	-53,061 Reduced 90.66%	5,464 $429,000
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $2.21 Million - $3.35 Million	-41,117 Reduced 41.26%	58,525 $3.34 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $1.91 Million - $4.85 Million	-51,814 Reduced 34.21%	99,642 $8.35 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $3.5 Million - $5.88 Million	151,456 New	151,456 $5.43 Million
Q4 2018 Feb 14, 2019	SELL	$13.88 - $21.75 $145,573 - $228,114	-10,488 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $130,680 - $228,009	10,488 New	10,488 $228,000

Others Institutions Holding DNLI

# of Institutions

226

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account